| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/11/2004 | EP1443909A1 Process for preparing dry extracts |
| 08/11/2004 | EP1443907A1 Biocompatible polymer blends and uses thereof |
| 08/11/2004 | EP1443904A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel |
| 08/11/2004 | EP1443903A2 Proliposomal drug delivery system |
| 08/11/2004 | EP1443901A2 Soluble drug extended release system |
| 08/11/2004 | EP1443899A2 Bowel cleansing agent |
| 08/11/2004 | EP1399531A4 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 08/11/2004 | EP1365764A4 Oral pharmaceutical composition of cefpodoxime proxetil |
| 08/11/2004 | EP1330253B1 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 08/11/2004 | EP1324782B1 Stabilized ophthalmic hydrogen peroxide solutions |
| 08/11/2004 | EP1272044B1 Protein stabilised emulsions |
| 08/11/2004 | EP1246641B1 Bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 08/11/2004 | EP1233750B1 Novel positive latex and use in cosmetics |
| 08/11/2004 | EP1135164B1 Composition for the treatment of inflammation |
| 08/11/2004 | EP1042007B1 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |
| 08/11/2004 | EP1028991B1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/11/2004 | EP0996508B1 Film coatings and film coating compositions based on dextrin |
| 08/11/2004 | EP0954288B1 Solid solution of an antifungal agent with enhanced bioavailability |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | EP0779922B1 Modified human c3 proteins |
| 08/11/2004 | CN1520516A T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/11/2004 | CN1520437A Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 08/11/2004 | CN1520435A Lipid-polymer-conjugates compsns. |
| 08/11/2004 | CN1520425A Superabsorber, method for prodn. and use thereof |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520325A Antitumoral formulations of thioxanthenone |
| 08/11/2004 | CN1520318A Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 08/11/2004 | CN1520306A Methods and devices for tissure repair |
| 08/11/2004 | CN1520305A Compsns. for preparing external carbon dioxide agents |
| 08/11/2004 | CN1520304A Xenogenic oligo of or/and polyribonucleotides as agents for treatment of malignant twnours |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520292A Medicinal compsns. |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520286A Gastric retention controlled drug delivery system |
| 08/11/2004 | CN1520285A Tablet comprising cetirizine and pseudoephedrine |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519032A Plasmid for gene therapy of cardiac muscle |
| 08/11/2004 | CN1161396C Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties |
| 08/11/2004 | CN1161157C Plaster matrix and its prepn. |
| 08/11/2004 | CN1161156C The use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability |
| 08/11/2004 | CN1161155C Use of inorganic aerogels in pharmacy |
| 08/11/2004 | CN1161150C Pharmaceutical compositions |
| 08/11/2004 | CN1161149C Cytokine and hemopoietic factor endogenous production enhancer and method of use thereof |
| 08/11/2004 | CN1161127C Cross-linked polysaccharide drug carrier |
| 08/11/2004 | CN1161122C Novel Composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 08/11/2004 | CN1161117C Medicinal compositions |
| 08/11/2004 | CN1161115C Inclusion complex |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/11/2004 | CN1161109C Fluoxetine enteric micropills |
| 08/11/2004 | CN1161108C Method for preparing pills containing 90 wt.% activated pharmaceutical compositions |
| 08/11/2004 | CN1161107C Oral formulation for gastrointestinal drug delivery |
| 08/11/2004 | CN1161102C Topical hormonal composition with systemic effect |
| 08/11/2004 | CN1161101C Conversion of liquid filled gelation capsules into controlled release systems by multiple coatings |
| 08/10/2004 | US6774247 Aqueous solution of ascorbic acid and method for producing same |
| 08/10/2004 | US6774228 1,4,7,10-tetrazacyclododecanes capable of reacting with monoclonal or polyclonal antibody; imaging |
| 08/10/2004 | US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging |
| 08/10/2004 | US6774180 For conjugation with biologically active agent is selected from a protein, peptide, carbohydrate, oligonucleotide, dna, rna, and lipid |
| 08/10/2004 | US6774137 For therapy of temporary prevention of itching of the eye due to allergic conjunctivitis |
| 08/10/2004 | US6774122 Sustained release; injection of fulvestrant |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774113 Process for preparing solubilization adjuvants from fusel oils and saccharides |
| 08/10/2004 | US6774108 Administering to mammal a therapeutically effective amount of recombinant human alpha-fetoprotein or a fragment thereof for inhibiting transplant rejection |
| 08/10/2004 | US6774105 Methods of using latent TGF-β binding proteins |
| 08/10/2004 | US6774104 Cyclic polypeptide stabilized with lactose |
| 08/10/2004 | US6774100 Cosmetics, drugs |
| 08/10/2004 | US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments) |
| 08/10/2004 | US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in |
| 08/10/2004 | US6773823 Sequential synthesis of core-shell nanoparticles using reverse micelles |
| 08/10/2004 | US6773724 Improved solubility |
| 08/10/2004 | US6773723 Collagen/polysaccharide bilayer matrix |
| 08/10/2004 | US6773720 Inner lipophilic and outher hydrophilic matrixs; high active ingredient content |
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773715 Preparation and use of solidified oils |
| 08/10/2004 | US6773714 Polymeric delivery formulations of leuprolide with improved efficacy |
| 08/10/2004 | US6773707 Employing hybrid antigen complex |
| 08/10/2004 | US6773341 Ventilating device for ventilating through a ridge |
| 08/10/2004 | CA2311354C Transdermal therapeutic system (tts) containing oxybutynin |
| 08/10/2004 | CA2273498C Cross-linked protein gels and methods of making them |
| 08/10/2004 | CA2234899C Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist, method for preparation and use thereof in the treatment of cardiovascularillnesses |
| 08/10/2004 | CA2191773C Stable gel formulation for topical treatment of skin conditions |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/05/2004 | WO2004065636A1 Solid surface for biomolecule delivery and high-throughput assay |
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | WO2004065440A2 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/05/2004 | WO2004064867A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 08/05/2004 | WO2004064850A1 Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent |
| 08/05/2004 | WO2004064847A1 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers |
| 08/05/2004 | WO2004064839A1 Salts of codrugs of an opioid together with a second active moiety and uses thereto |
| 08/05/2004 | WO2004064830A1 Processed fat compositions for preventing and improving lifestyle-related diseases |
| 08/05/2004 | WO2004064822A1 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2004 | WO2004064811A1 A composition material for transmucosal delivery |
| 08/05/2004 | WO2004064804A1 Povidone-iodine-based ophthalmological preparations |
| 08/05/2004 | WO2004064788A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064777A2 Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer |
| 08/05/2004 | WO2004064769A2 Methods for making and using topical delivery agents |
| 08/05/2004 | WO2004064761A2 Therapeutically active compounds |
| 08/05/2004 | WO2004064760A2 Aptamer therapeutics useful in ocular pharmacotherapy |
| 08/05/2004 | WO2004064758A2 Improved oral delivery of peptides |